Segment Information (Tables)

12 Months Ended

Dec. 31, 2014

Segment Reporting [Abstract]

Schedule of Segment Reporting Information by Segment

Sale of product	2014		2013
Radiochemical products	$	1,742,495	$	1,636,535
Cobalt products		1,791,906		1,080,011
Nuclear medicine standards		3,267,254		3,249,126
Radiological services		621,431		763,980
Fluorine products		-		-
Transportation		113,775		119,498
Total segments		7,536,860		6,849,150
Corporate revenue		-		-
Total consolidated	$	7,536,860	$	6,849,150

Depreciation and amortization	2014		2013
Radiochemical products	$	7,178	$	33,027
Cobalt products		73,071		80,929
Nuclear medicine standards		19,162		20,856
Radiological services		29,436		10,333
Fluorine products		109,253		187,831
Transportation		6,780		12,873
Total segments		244,880		345,849
Corporate depreciation and amortization		96,538		69,758
Total consolidated	$	341,418	$	415,607

Segment income (loss)	2014		2013
Radiochemical products	$	366,223	$	223,011
Cobalt products		736,405		62,791
Nuclear medicine standards		636,322		609,107
Radiological services		201,169		430,525
Fluorine products		(418,887)		(819,848)
Transportation		(24,653)		(29,842)
Total segments		1,496,579		475,745
Corporate loss		(3,041,655)		(2,937,589)
Net loss	$	(1,545,077)	$	(2,461,845)

Expenditures for segment assets	2014		2013
Radiochemical products	$	53,320	$	4,356
Cobalt products		19,042		-
Nuclear medicine standards		528		3,540
Radiological services		2,632		150,840
Fluorine products		39,866		413,365
Transportation		-		-
Total segments		115,388		572,101
Corporate purchases		-		-
Total consolidated	$	115,388	$	572,101

Segment assets	2014		2013
Radiochemical products	$	230,257	$	153,305
Cobalt products		1,035,226		1,574,603
Nuclear medicine standards		564,034		573,389
Radiological services		381,898		608,949
Fluorine products		5,996,258		6,093,151
Transportation		8,434		12,864
Total segments		8,216,107		9,016,261
Corporate assets		2,734,030		2,991,753
Total consolidated	$	10,950,137	$	12,008,014